SLE logo

Super League Enterprise (SLE) News & Sentiment

Super League Enterprise (SLE) Moves to Buy: Rationale Behind the Upgrade
Super League Enterprise (SLE) Moves to Buy: Rationale Behind the Upgrade
Super League Enterprise (SLE) Moves to Buy: Rationale Behind the Upgrade
SLE
zacks.comAugust 23, 2024

Super League Enterprise (SLE) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

Super League Enterprise (SLE) Reports Q2 Loss, Misses Revenue Estimates
Super League Enterprise (SLE) Reports Q2 Loss, Misses Revenue Estimates
Super League Enterprise (SLE) Reports Q2 Loss, Misses Revenue Estimates
SLE
zacks.comAugust 14, 2024

Super League Enterprise (SLE) came out with a quarterly loss of $0.60 per share versus the Zacks Consensus Estimate of a loss of $0.62. This compares to loss of $3.40 per share a year ago.

Super League Announces Second Quarter 2024 Financial Results
Super League Announces Second Quarter 2024 Financial Results
Super League Announces Second Quarter 2024 Financial Results
SLE
globenewswire.comAugust 14, 2024

~ Q2 2024 Highlighted by Launch of Innovative Scalable Products, SOUNDZ and Unlockables, New Dedicated Worlds and a Strategic Partnership with Meta-Stadiums~

Super League Sets Second Quarter 2024 Earnings Date, August 14, 2024
Super League Sets Second Quarter 2024 Earnings Date, August 14, 2024
Super League Sets Second Quarter 2024 Earnings Date, August 14, 2024
SLE
globenewswire.comAugust 1, 2024

SANTA MONICA, Calif., Aug. 01, 2024 (GLOBE NEWSWIRE) -- Super League (Nasdaq: SLE) (the “Company”), a leader in redefining the gaming industry as a media channel, announced today that the Company will post its second quarter 2024 financial results after market close on Wednesday, August 14, 2024. A webinar will be held the same day at 5:00 pm Eastern Time to discuss the results and can be accessed using the below dial-in numbers or registration link.

Cartesian Therapeutics Announces First Patient Dosed in Phase 2 Trial of Descartes-08 in Systematic Lupus Erythematosus
Cartesian Therapeutics Announces First Patient Dosed in Phase 2 Trial of Descartes-08 in Systematic Lupus Erythematosus
Cartesian Therapeutics Announces First Patient Dosed in Phase 2 Trial of Descartes-08 in Systematic Lupus Erythematosus
SLE
globenewswire.comJuly 2, 2024

Trial to assess outpatient administration without lymphodepleting chemotherapy in patients with SLE Trial to assess outpatient administration without lymphodepleting chemotherapy in patients with SLE

Super League Issues Mid-Year Update, Expects Record 2024 Revenues
Super League Issues Mid-Year Update, Expects Record 2024 Revenues
Super League Issues Mid-Year Update, Expects Record 2024 Revenues
SLE
globenewswire.comJune 21, 2024

SANTA MONICA, Calif., June 21, 2024 (GLOBE NEWSWIRE) -- Super League (Nasdaq: SLE) (the “Company”), a leading creator and publisher of content experiences and media solutions across the world's largest immersive platforms, today issued a mid-year update from the Company's Chief Executive Office, Ann Hand.

Super League Enterprise, Inc. (SLE) Q1 2024 Earnings Call Transcript
Super League Enterprise, Inc. (SLE) Q1 2024 Earnings Call Transcript
Super League Enterprise, Inc. (SLE) Q1 2024 Earnings Call Transcript
SLE
seekingalpha.comMay 15, 2024

Welcome to the Super League First Quarter 2024 Conference Call, hosted by CEO Ann Hand. Thank you for joining us.

Super League Enterprise, Inc. (SLE) Q4 2023 Earnings Call Transcript
Super League Enterprise, Inc. (SLE) Q4 2023 Earnings Call Transcript
Super League Enterprise, Inc. (SLE) Q4 2023 Earnings Call Transcript
SLE
Seeking AlphaMarch 27, 2024

Super League Enterprise, Inc. (SLE) Q4 2023 Earnings Call Transcript

Super League Enterprise (SLE) Reports Q4 Loss, Tops Revenue Estimates
Super League Enterprise (SLE) Reports Q4 Loss, Tops Revenue Estimates
Super League Enterprise (SLE) Reports Q4 Loss, Tops Revenue Estimates
SLE
Zacks Investment ResearchMarch 27, 2024

Super League Enterprise (SLE) came out with a quarterly loss of $3.47 per share versus the Zacks Consensus Estimate of a loss of $1.23. This compares to loss of $4.20 per share a year ago.

Super League Sets Fourth Quarter and Full Year 2023 Earnings Date, March 27, 2024
Super League Sets Fourth Quarter and Full Year 2023 Earnings Date, March 27, 2024
Super League Sets Fourth Quarter and Full Year 2023 Earnings Date, March 27, 2024
SLE
GlobeNewsWireMarch 13, 2024

~ Company Previously Pre-Announced Preliminary Record Fourth Quarter 2023 Revenue of $9.4 million, an Increase of Approximately 32% Year-over-Year ~ ~ Company Previously Pre-Announced Preliminary Record Fourth Quarter 2023 Revenue of $9.4 million, an Increase of Approximately 32% Year-over-Year ~

  • 1(current)
  • 2
  • 1(current)
  • 2